Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes

Blood

Volumn 111, Issue 7, 2008, Pages 3553-3561

  Crist, Scott A ^a,b   Sprague, Daniel L ^a   Ratliff, Timothy L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD40 LIGAND; CYTOKINE; FIBRINOGEN RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; ANIMAL; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CELL STRAIN HL 60; CELL STRAIN K 562; CYTOLOGY; GENE EXPRESSION REGULATION; HELA CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; CARDIOVASCULAR DISEASES; CD40 LIGAND; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; HELA CELLS; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; K562 CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MEGAKARYOCYTES; MICE; NFATC TRANSCRIPTION FACTORS; T-LYMPHOCYTES;

EID: 43549095989     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-05-088161     Document Type: Article

References (45)

1. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 2001 ;S8:4-43.
2. Schonbeck U, Mach F, Libby P. CD154(CD40 ligand). Int J Biochem Cell Biol. 2000;32:687-693.
3. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67:2-17.
4. Aldinucci D, Poletto D, Nanni P, et al. CD40L induces proliferation, self-renewal, rescue from apoptosis. and production of cytokines by CD40-expressing AML blasts. Exp Hematol. 2002;30:1283-1292.
5. Inwald DP. Peters MJ, Walshe D, Jones A, Davies EG, Klein NJ. Absence of platelet CD40L identifies patients with X-linked hyper lgM syndrome. Clin Exp Immunol. 2000;120:499-502.
6. Javaid B, Quigg RJ. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int. 2005;67:1692-1703.
7. Moore WV, Chu w, Tong PY. et al. Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade. J Autoimmun. 2002;19:139-145.
8. Phipps RP, Koumas L, Leung E. Reddy SY. Blieden T, Kaufman J. The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Investig Drugs. 2001 ;2:773-777.
9. Urbich C, Dimmeler S. CD40 and vascular inflammation. Can J Cardiol. 2004;20:681 -683.
10. Yazdany J, Davis J. The role of CD40 ligand in systemic lupus erythematosus. Lupus. 2004;13: 377-380.
11. Cipollone F, Chiarelli F, Davi G, et al. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control. Diabetologia. 2005;48:1216-1224.
12. Cipollone F, Ferri C, Desideri G. et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation. 2003;108:2776-2782.
13. Crow MK, Kirou KA. Regulation of CD40 ligand expression in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13:361-369.
14. Mach F, Schonbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis. 1998;137:S89-S95.
15. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394: 200-203.
16. Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U SA. 1997;94:1931-1936.
17. Balow JE, Austin HA 3rd. Progress in the treatment of proliferative lupus nephritis. Curr Opin Nephrol Hypertens. 2000;9:107-115.
18. Kato K, Santana-Sahagun E, Rassenti LZ, et al. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest. 1999;104:947-955.
19. Zandman-Goddard G, Shoenfeld Y. Novel approaches to therapy tor SLE. Clin Rev Allergy Immunol. 2003;25:105-112.
20. Zandman-Goddard G, Shoenteld Y. Novel approaches to therapy tor systemic lupus erythematosus. Eur J Intern Med. 2000;11:130-134.
21. Henn V, Slupsky JR, Grate M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391: 591-594.
22. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood. 2001;98:1047-1054.
23. Lobo FM, Xu S, Lee C, Fuleihan RL. Transcriptional activity of the distal CD40 ligand promoter. Biochem Biophys Res Commun. 2000;279:245- 250.
24. Luo C, Burgeon E, Rao A. Mechanisms of transactivation by nuclear factor of activated T cells-1. J Exp Med. 1996;184:141-147.
25. Quintana A, Griesemer D, Schwarz EC, Hoth M. Calcium-dependent activation of T-lymphocytes. Pflugers Arch. 2005;450:1-12.
26. Lindgren H, Axcrona K. Leanderson T. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J Immunol. 2001 ;166:4578-4585.
27. Oum JH, Han J, Myung H, Hleb M, Sharma S, Park J. Molecular mechanism of NFAT family proteins for differential regulation of the IL-2 and TNF-alpha promoters. Mol Cells. 2002;13:77-84.
28. Rao A, Luo C, Hogan PG. Transcription factors of the N FAT family: regulation and function. Annu Rev Immunol. 1997;15:707-747.
29. Stankunas K, Graef IA, Neilson JR, Park SH, Crabtree GR. Signaling through calcium, calcineurin, and NF-AT in lymphocyte activation and development. Cold Spring Harb Symp Quant Biol. 1999;64:505-516.
30. Alvarez-Arroyo MV, Yague S, Wenger RM, et al. Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: role of vascular endothelial growth factor. Circ Res. 2002;91:202-209.
31. Dumont FJ. FK506, an immunosuppressant tar geting calcineurin function. Curr Med Chem. 2000;7:731-748.
32. Colgan J, Asmal M, Yu B, Luban J. Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine. J Immunol. 2005;174:6030-6038.
33. Tani T, Ylanne J, Virtanen I. Expression of megakaryocytc and erythroid properties in human leukemic cells. Exp Hematol. 1996;24:158-168.
34. Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res. 2003;27: 185-202.
35. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002:106:896-899.
36. Aukrust P, Damas JK, Solum NO. Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation? J Am Coll Cardiol. 2004;43:2326-2328.
37. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl. 2005:6:21-29.
38. Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol. 2005;25:103-121.
39. Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res. 2003;92:944-946.
40. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115:3378-3384.
41. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924-931.
42. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. Embo J. 2002;21: 5225-5234.
43. Yang M, Li K. The role of cytokines and transcription factors in megakaryocytopoiesis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2002;10:580-585.
44. Kiani A, Habermann l Haase M, et al. Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation. J Leukoc Biol. 2004:76:1057-1065.
45. Kiani A, Kuithan H, Kuithan F, et al. Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes. Exp Hematol. 2007;35:757-770.